3WEST DEVELOPMENTS LTD

Executive Summary

3West Developments Ltd has made a notable recovery from prior financial distress, now showing positive liquidity and net assets. While the company’s financial health has improved, attention must be paid to managing receivables and liabilities to sustain this momentum. With prudent financial controls and monitoring, the company is positioned for a stable and potentially prosperous future.

3WEST DEVELOPMENTS LTD - Analysis Report

Company Number: 13133465

Analysis Date: 2025-07-20 11:53 UTC

Financial Health Assessment for 3WEST DEVELOPMENTS LTD as of 31 December 2023

---

1. Financial Health Score: B-

Explanation:
3West Developments Ltd displays significant improvement in its financial condition over the latest year, moving from negative net assets and working capital in 2022 to positive territory in 2023. This indicates a recovery phase with strengthening financial foundations. However, the company still carries some risk due to moderate liquidity and reliance on debtors. The score B- reflects a cautiously improving but not yet robust financial health.

---

2. Key Vital Signs

Metric	2023 Value	Interpretation
Net Current Assets (Working Capital)	£384,012	Positive working capital suggests the company can cover short-term obligations comfortably, a sign of healthy liquidity.
Net Assets (Equity)	£442,964	Positive net assets after previous years of deficit indicate restored shareholder value and solvency.
Cash at Bank	£690,165	Healthy cash reserves provide a strong cash flow cushion — a vital sign of operational liquidity.
Current Liabilities	£1,071,657	Substantial current liabilities but reduced significantly from previous year, showing less pressure on near-term obligations.
Debtors (Trade & Other)	£765,504	High debtors imply potential cash flow risks if collections are delayed; monitoring is required.
Tangible Fixed Assets	£58,952	Modest fixed asset base, typical for a real estate letting operation, showing investment in operational capacity.
Share Capital	£1	Minimal paid-up share capital; equity relies mostly on retained earnings.

---

3. Diagnosis: Financial Condition Analysis

• Liquidity Pulse: The company shows a "healthy cash flow pulse" with ample cash and positive working capital in 2023 after a period of distress in 2022. This improvement suggests effective management of payables and receivables, easing short-term financial strain.

• Balance Sheet Vitality: The turnaround from a negative net asset position (-£305,958 in 2022) to a positive equity position (£442,964 in 2023) signals a strong recovery. This is akin to a patient coming out of a critical condition, now stabilizing with improved reserves.

• Receivables Concerns: The large balance of debtors (£765,504) compared to cash indicates some risk. If debtor collection slows or deteriorates, it could cause liquidity "symptoms" such as cash shortages. The company should monitor credit control closely.

• Liabilities Management: Substantial current liabilities have been reduced by nearly half from the prior year, which is a positive "symptom" of debt control and better short-term financial planning.

• Asset Base: Fixed assets have increased moderately, consistent with growth or reinvestment in operational infrastructure, supporting future revenue generation.

• Profitability & Reserves: While detailed profit and loss data is not disclosed, the movement from accumulated losses to a positive retained earnings reserve indicates recent profitability or capital injection, a sign of improved financial health.

---

4. Recommendations: Steps to Enhance Financial Wellness

• Enhance Debtor Management: Implement stricter credit control policies and improve collection procedures to convert receivables into cash more rapidly, strengthening liquidity.

• Maintain Cash Buffers: Continue to sustain or increase cash reserves to absorb operational shocks or unexpected expenses, much like maintaining a healthy heartbeat rate in finance.

• Monitor Liability Levels: Keep current liabilities under close watch to avoid liquidity crunches; negotiate better payment terms with suppliers if possible.

• Consider Capital Injection: Given minimal share capital, the company might explore equity funding to bolster the balance sheet further, reducing financial leverage and volatility.

• Regular Financial Health Checks: Establish routine internal reviews of key financial metrics (working capital, cash flow, debt levels) to identify early signs of financial distress and address them proactively.

• Plan for Growth with Caution: Investments in fixed assets should align with clear revenue growth plans to avoid overextension of resources.

---